Dedicated to finding a
cure for brain cancer
2024 Grant Awards
Applications Accepted No Earlier Than January 1, 2024
Emerging Leader Grant Award
The Ben & Catherine Ivy Foundation Emerging Leader Award provides grant support to early-to-mid-career investigators conducting high-impact, high-reward translational research for glioblastoma. This award is intended to support ambitious pilot projects designed to identify drug strategies appropriate for early-phase pharmacodynamic- and pharmacokinetic-driven clinical trials in partnership with the Ivy Brain Tumor Center.
Translational Adult Glioma Award
The Ben & Catherine Ivy Foundation Emerging Adult Glioma Award provides grant support to investigators conducting high-impact, high-reward translational research for glioblastoma. This award is intended to support projects designed to contribute to identifying therapies that will impact the survival of patients with brain cancer.
The Ivy Brain Tumor Center is a non-profit translational research program that employs a bold, early-phase clinical trials strategy to identify new treatments for aggressive brain tumors, including glioblastoma.
Ivy Phase 0 Clinical Trials
The Ivy Center’s Phase 0 clinical trials program is the largest of its kind in the world and enables personalized care in a fraction of the time and cost associated with traditional drug development. Unlike conventional clinical trials focusing on single drugs, the Ivy Center’s accelerated trials program tests therapeutic combinations matched to individual patients.
Meet Jenn, a mother of two and the life of the party. When she was diagnosed with glioblastoma and facing brain surgery, her main concern was preserving her sense of humor. She’s fought through surgery and treatment, a tumor recurrence and another round of surgery and treatment. Jenn enrolled in an Ivy Brain Tumor Center Phase 0 clinical trial and today, three years later, she’s happy, healthy and still making everyone around her laugh.
Ivy Center Headquarters
Opening in 2024
The Ivy Brain Tumor Center is well underway on the construction of its new headquarters, the world’s largest translational research center dedicated solely to brain tumor drug development and treatment. The new building, located on the Dignity Health St. Joseph’s Hospital and Medical Center campus in Phoenix, Arizona, will be home to the Ivy Center’s scientists, investigators, clinicians and operational staff. In addition to laboratory space, the new building will house 14,000 square feet for trials infrastructure and 7,000 square feet for multidisciplinary clinical consultation, an MRI-guided ultrasound suite and a video teleconference auditorium.
The Ivy Center and Ivy Foundation
Sanjiv Sam Gambhir M.D., Ph.D
Ivy Foundation Honored
Support Brain Tumor Research
Donations to the Ben and Catherine Ivy Foundation can be made via check and mailed to:
6710 North Scottsdale Road, #235, Scottsdale, AZ 85253
Donations to the Ivy Brain Tumor Center at Barrow Neurological Institute can be made via the link below.
A Message from Catherine Ivy
The Ivy Foundation has the long-term, ultimate goal to cure brain cancer. To that end, we fund cutting-edge research that will improve diagnostics and treatment options for patients with brain cancer. Since 2005, we’ve committed more than $135 million to brain tumor research, with the expectation that this will lead to an eventual cure. We are dedicated to this effort because funding leads to answers, and answers lead to hope.